Answer
Rare but severe, potentially life-threatening Stevens-Johnson syndrome and erythema multiforme have been reported after marketing with varenicline; patients should stop treatment at the first sign of rash or skin reaction and contact a healthcare provider immediately.
Sources for this answer
- Varenicline 1 mg film-coated tabletsBrown & Burk UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 1Document updated
Sources checked